Eugene

[email protected]

LATEST

Recipharm Divests Rights to Thyroid Protection Drug
By

By
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has divested its rights, except in the US, for a potassium iodide product, ThyroSafe, to SERB SA, a Brussels, Belgium-headquartered specialty…

Brammer Bio, Sarepta in Gene-Therapy Mfg Pact
By

By
Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, has formed a long-term manufacturing partnership for gene-therapy with Brammer Bio, a Lexington, Massachusetts-headquartered cell…

FDA Commissioner Details FY19 Budget Request to Support Generic-Drug Competition
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb issued a statement to highlight President Donald Trump’s fiscal year 2019 budget request for the FDA that includes funding of $37.6…

Indivior, Dr. Reddy’s in Dispute Over Anti-Opioid Dependence Drug
By

By
A federal US district court has granted Indivior, a Slough, UK-headquartered pharmaceutical company, a temporary restraining order (TRO) that compels Dr. Reddy’s Laboratories to immediately cease launch activities related to its…

Senate Committee Holds Hearing on Drug Pricing with HHS Secretary
By

By
The US Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing this week (June 12, 2018) with Secretary of the Department of Health and Human Services (HHS)…

Recipharm Acquires Sanofi’s UK CMO Inhalation-Drug Business
By

By
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has agreed to acquire Sanofi’s contract manufacturing business for respiratory products in Holmes Chapel, England for approximately $60 million. The business…

J&J Accepts Offer for LifeScan Diabetes-Care Unit for $2.1 Billion
By

By
Johnson & Johnson (J&J) has agreed to sell its LifeScan business, a diabetes-care unit, to Platinum Equity, a private investment firm, for approximately $2.1 billion by accepting the binding offer…

FDA Closes Two-Year Inspection on Sun Pharma’s Injectables Manufacturing Facility
By

By
The US Food and Drug Administration (FDA) has issued an Establishment Inspection Report (EIR) to Sun Pharmaceutical Industries, a Mumbai, India-headquartered pharmaceutical company, for Sun Pharmaceutical’s injectables facility in Gujarat,…

Thermo Fisher Scientific Opens US Precision Medicine Science Center
By

By
Thermo Fisher Scientific has opened a US Precision Medicine Science Center (PMSC) in Cambridge, Massachusetts. The center offers access to technologies to help collaborators develop analytical workflows that generate precise…

AMRI Signs NIH Contract for API and Drug-Product Mfg
By

By
AMRI, a contract research, development, and manufacturing organization, has signed a seven-year contract with the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health…